Mohammed Shameem

Senior Vice President, Drug Product Development and Technology · Regeneron Pharmaceuticals

Biopharmaceuticals

Mohammed Shameem is senior vice president of drug product development and technology at Regeneron Pharmaceuticals. He joined in 2016 after biologics development and commercialization leadership at Merck.

Last reviewed: Oct 21, 2026

Mohammed Shameem

Senior Vice President, Drug Product Development and Technology Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Mohammed Shameem is senior vice president of drug product development and technology at Regeneron Pharmaceuticals. He joined in 2016 after biologics development and commercialization leadership at Merck.

Career Highlights

  • Joined Regeneron in 2016.
  • Leads drug product development across therapeutic modalities, dosage forms and administration routes.
  • Received American Chemical Society awards in 2016 and 2021.

Professional Journey

Shameem held leadership roles in biologics development and commercialization at Merck before joining Regeneron in 2016.

He now leads Drug Product Development and Technology. His group develops drug products across therapeutic modalities, dosage forms and routes of administration. His responsibilities also include expansion into genetic medicines, fixed-dose combinations, manufacturing process development and advanced drug delivery systems.

His recognition includes the American Chemical Society’s Industrial Biotechnology Award in 2016 and Heroes of Chemistry Award in 2021. His education in pharmacy and pharmaceutical sciences preceded his industry work on product development and commercialization.

Education

Shameem earned BPharm and MPharm degrees from the University of Dhaka in Bangladesh and a PhD in pharmaceutical sciences from Kumamoto University in Japan.